SWOT ANALYSIS OF ZANDU PANCHARISHTA

Description
SWOT ANALYSIS OF ZANDU PANCHARISHTA

Zandu Pancharishta

Parent Company

Emami/ Zandu

Category

FMCG

Sector

Healthcare

Tagline/ Slogan

Complete Ayurvedic digestive tonic

Special Ayurvedic formulation that doesn’t address symptoms but the USP root cause and thus permanent relief from stomach problems STP

Segment

OTC Medicine

Target Group

Middle and old age groups across middle and lower class

an Ayurvedic digestive tonic which cures all digestive problems such as gas, acidity, constipation, flatulence, stomach pain, indigestion, Positioning builds immunity and strengthens the digestive system SWOT Analysis

1. Zandu is a century old household name in Ayurvedic products and thus the product also benefits from the strong brand name association 2. Advertising by showing medifacts about how Pancharisht is better than other remedies in the market gives it a differentiation 3. Endorsement by celebrities aids to better brand recall across all age groups and demographics 4. The company intends to focus strongly on the Ayurvedic properties of brands in its portfolio. They have a dedicated website that provides Strength information about the herbal ingredients, dosage required etc.

1. The brand has no connect with the youngsters and children who Weakness might not develop an association with it as they become the target group later in life

2. It has not been able to create a position for itself amidst so may fast relief medicines available

1. With the kind of food habits developing and increased dependency on fast food, people frequently suffer from indigestion and demand for Ayurvedic remedies would rise 2. The brand can target youth also since with the kind of stress and hectic lifestyles, they also suffer from such problems and can start using the product 3. It can leverage on the integrated distribution network of Zandu Opportunity and Emami

1. With rising incomes, the middle class has started preferring international health brands 2. With unique ingredients required, the climbing raw material costs will hit the margins 3. The customers’ perception that Ayurvedic medicines act slow as Threats compared to allopathic might restrict its growth Competition

1. Eno Competitors 2. Kayam Churna



doc_401591406.docx
 

Attachments

Back
Top